APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI in Respiratory Diseases

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AI in Respiratory Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026199 pages

Choose your research edition.

Industry ResearchAI in Respiratory Diseases Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI in Respiratory Diseases Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI in Respiratory Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI in Respiratory Diseases Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal AI in Respiratory Diseases Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global AI in Respiratory Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AI in Respiratory Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AI in Respiratory Diseases include ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily and VIDA Diagnostics Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AI in Respiratory Diseases market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI in Respiratory Diseases and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI in Respiratory Diseases revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AI in Respiratory Diseases market size, projected growth trends, production technologies, key applications, and end-use industries.

AI in Respiratory Diseases Segment by Company

ArtiQ

Philips Healthcare

GE Healthcare

Siemens Healthineers

Swaasa AI

THIRONA

DeepMind Health

Verily

VIDA Diagnostics Inc

Icometrix

Infervision

PneumoWave

Respiray

Dectrocel Healthcare

Zynnon

AI in Respiratory Diseases Segment by Type

Pulmonary Infection

MRI

CT Scan

AI in Respiratory Diseases Segment by Application

Hospital

Diagnostic Centers

Ambulatory Surgical Centers

Others

AI in Respiratory Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI in Respiratory Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI in Respiratory Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI in Respiratory Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AI in Respiratory Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI in Respiratory Diseases industry.

Chapter 3: Detailed analysis of AI in Respiratory Diseases companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI in Respiratory Diseasesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pulmonary Infection Table 3. Key Players of MRI Table 4. Key Players of CT Scan Table 4. Global AI in Respiratory Diseases Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Diagnostic Centers Table 7. Key Players of Ambulatory Surgical Centers Table 8. Key Players of Others Table 9. Global AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global AI in Respiratory Diseases Market Size by Region (2021-2026) & (US$ Million) Table 11. Global AI in Respiratory Diseases Market Share by Region (2021-2026) Table 12. Global AI in Respiratory Diseases Market Size by Region (2027-2032) & (US$ Million) Table 13. Global AI in Respiratory Diseases Market Share by Region (2027-2032) Table 14. AI in Respiratory Diseases Industry Trends Table 15. AI in Respiratory Diseases Industry Drivers Table 16. AI in Respiratory Diseases Industry Opportunities and Challenges Table 17. AI in Respiratory Diseases Industry Restraints Table 18. Global AI in Respiratory Diseases Revenue by Company (US$ Million) & (2021-2026) Table 19. Global AI in Respiratory Diseases Revenue Market Share by Company (2021-2026) Table 20. Global AI in Respiratory Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global AI in Respiratory Diseases Key Company Head Office and Area Served Table 22. Global AI in Respiratory Diseases Company, Product Type & Application Table 23. Global AI in Respiratory Diseases Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global AI in Respiratory Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global AI in Respiratory Diseases Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 28. Global AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 29. Global AI in Respiratory Diseases Revenue Market Share by Type (2021-2026) Table 30. Global AI in Respiratory Diseases Revenue Market Share by Type (2027-2032) Table 31. Global AI in Respiratory Diseases Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 33. Global AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 34. Global AI in Respiratory Diseases Revenue Market Share by Application (2021-2026) Table 35. Global AI in Respiratory Diseases Revenue Market Share by Application (2027-2032) Table 36. ArtiQ Company Information Table 37. ArtiQ Business Overview Table 38. ArtiQ AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. ArtiQ AI in Respiratory Diseases Product Portfolio Table 40. ArtiQ Recent Development Table 41. Philips Healthcare Company Information Table 42. Philips Healthcare Business Overview Table 43. Philips Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Philips Healthcare AI in Respiratory Diseases Product Portfolio Table 45. Philips Healthcare Recent Development Table 46. GE Healthcare Company Information Table 47. GE Healthcare Business Overview Table 48. GE Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. GE Healthcare AI in Respiratory Diseases Product Portfolio Table 50. GE Healthcare Recent Development Table 51. Siemens Healthineers Company Information Table 52. Siemens Healthineers Business Overview Table 53. Siemens Healthineers AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Siemens Healthineers AI in Respiratory Diseases Product Portfolio Table 55. Siemens Healthineers Recent Development Table 56. Swaasa AI Company Information Table 57. Swaasa AI Business Overview Table 58. Swaasa AI AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Swaasa AI AI in Respiratory Diseases Product Portfolio Table 60. Swaasa AI Recent Development Table 61. THIRONA Company Information Table 62. THIRONA Business Overview Table 63. THIRONA AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. THIRONA AI in Respiratory Diseases Product Portfolio Table 65. THIRONA Recent Development Table 66. DeepMind Health Company Information Table 67. DeepMind Health Business Overview Table 68. DeepMind Health AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. DeepMind Health AI in Respiratory Diseases Product Portfolio Table 70. DeepMind Health Recent Development Table 71. Verily Company Information Table 72. Verily Business Overview Table 73. Verily AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Verily AI in Respiratory Diseases Product Portfolio Table 75. Verily Recent Development Table 76. VIDA Diagnostics Inc Company Information Table 77. VIDA Diagnostics Inc Business Overview Table 78. VIDA Diagnostics Inc AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. VIDA Diagnostics Inc AI in Respiratory Diseases Product Portfolio Table 80. VIDA Diagnostics Inc Recent Development Table 81. Icometrix Company Information Table 82. Icometrix Business Overview Table 83. Icometrix AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Icometrix AI in Respiratory Diseases Product Portfolio Table 85. Icometrix Recent Development Table 86. Infervision Company Information Table 87. Infervision Business Overview Table 88. Infervision AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Infervision AI in Respiratory Diseases Product Portfolio Table 90. Infervision Recent Development Table 91. PneumoWave Company Information Table 92. PneumoWave Business Overview Table 93. PneumoWave AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. PneumoWave AI in Respiratory Diseases Product Portfolio Table 95. PneumoWave Recent Development Table 96. Respiray Company Information Table 97. Respiray Business Overview Table 98. Respiray AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Respiray AI in Respiratory Diseases Product Portfolio Table 100. Respiray Recent Development Table 101. Dectrocel Healthcare Company Information Table 102. Dectrocel Healthcare Business Overview Table 103. Dectrocel Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Dectrocel Healthcare AI in Respiratory Diseases Product Portfolio Table 105. Dectrocel Healthcare Recent Development Table 106. Zynnon Company Information Table 107. Zynnon Business Overview Table 108. Zynnon AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Zynnon AI in Respiratory Diseases Product Portfolio Table 110. Zynnon Recent Development Table 111. North America AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 112. North America AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 113. North America AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 114. North America AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 115. North America AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America AI in Respiratory Diseases Market Size by Country (2021-2026) Table 117. North America AI in Respiratory Diseases Market Size by Country (2027-2032) Table 118. Europe AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe AI in Respiratory Diseases Market Size by Country (2021-2026) Table 124. Europe AI in Respiratory Diseases Market Size by Country (2027-2032) Table 125. China AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 126. China AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 127. China AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 128. China AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia AI in Respiratory Diseases Market Size by Country (2021-2026) Table 135. Asia AI in Respiratory Diseases Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. AI in Respiratory Diseases Product Image Figure 2. Global AI in Respiratory Diseases Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AI in Respiratory Diseases Market Share by Type: 2025 VS 2032 Figure 4. Pulmonary Infection Image Figure 5. MRI Image Figure 6. CT Scan Image Figure 7. Global AI in Respiratory Diseases Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global AI in Respiratory Diseases Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Diagnostic Centers Image Figure 11. Ambulatory Surgical Centers Image Figure 12. Others Image Figure 13. Global AI in Respiratory Diseases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 15. Global AI in Respiratory Diseases Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global AI in Respiratory Diseases Market Share by Players in 2025 Figure 18. Global Top 5 and 10 AI in Respiratory Diseases Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global AI in Respiratory Diseases Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global AI in Respiratory Diseases Revenue Market Share by Type (2021-2032) Figure 22. Global AI in Respiratory Diseases Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AI in Respiratory Diseases Revenue Market Share by Application (2021-2032) Figure 24. North America AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 25. North America AI in Respiratory Diseases Market Share by Type (2021-2032) Figure 26. North America AI in Respiratory Diseases Market Share by Application (2021-2032) Figure 27. North America AI in Respiratory Diseases Market Share by Country (2021-2032) Figure 28. United States AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 29. Canada AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 30. Mexico AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 31. Europe AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 32. Europe AI in Respiratory Diseases Market Share by Type (2021-2032) Figure 33. Europe AI in Respiratory Diseases Market Share by Application (2021-2032) Figure 34. Europe AI in Respiratory Diseases Market Share by Country (2021-2032) Figure 35. Germany AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 36. France AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 37. U.K. AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 38. Italy AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 39. Russia AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 41. China AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 42. China AI in Respiratory Diseases Market Share by Type (2021-2032) Figure 43. China AI in Respiratory Diseases Market Share by Application (2021-2032) Figure 44. Asia AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 45. Asia AI in Respiratory Diseases Market Share by Type (2021-2032) Figure 46. Asia AI in Respiratory Diseases Market Share by Application (2021-2032) Figure 47. Asia AI in Respiratory Diseases Market Share by Country (2021-2032) Figure 48. Japan AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 49. South Korea AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 52. India AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 53. Australia AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa AI in Respiratory Diseases Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa AI in Respiratory Diseases Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa AI in Respiratory Diseases Market Share by Country (2021-2032) Figure 58. Brazil AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 59. South Africa AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 61. Turkey AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 62. Argentina AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 63. UAE AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 64. Egypt AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 65. Chile AI in Respiratory Diseases Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Pulmonary Infection
  • MRI
  • CT Scan
Applications
  • Hospital
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others
Companies covered
  • ArtiQ
  • Philips Healthcare
  • GE Healthcare
  • Siemens Healthineers
  • Swaasa AI
  • THIRONA
  • DeepMind Health
  • Verily
  • VIDA Diagnostics Inc
  • Icometrix
  • Infervision
  • PneumoWave
  • Respiray
  • Dectrocel Healthcare
  • Zynnon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AI in Respiratory Diseases Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pulmonary Infection
  5. 1.2.3 MRI
  6. 1.2.4 CT Scan
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global AI in Respiratory Diseases Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Diagnostic Centers
  11. 1.3.4 Ambulatory Surgical Centers
  12. 1.3.5 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global AI in Respiratory Diseases Growth Trends by Region
  15. 1.5.1 Global AI in Respiratory Diseases Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 AI in Respiratory Diseases Market Size by Region (2021-2026)
  17. 1.5.3 AI in Respiratory Diseases Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global AI in Respiratory Diseases Market Dynamics
  1. 2.1 AI in Respiratory Diseases Industry Trends
  2. 2.2 AI in Respiratory Diseases Industry Drivers
  3. 2.3 AI in Respiratory Diseases Industry Opportunities and Challenges
  4. 2.4 AI in Respiratory Diseases Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AI in Respiratory Diseases Revenue by Company (2021-2026)
  2. 3.2 Global AI in Respiratory Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AI in Respiratory Diseases Key Company Head office and Area Served
  4. 3.4 Global AI in Respiratory Diseases Company, Product Type & Application
  5. 3.5 Global AI in Respiratory Diseases Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AI in Respiratory Diseases Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AI in Respiratory Diseases Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AI in Respiratory Diseases Tier 1, Tier 2, and Tier 3
4 AI in Respiratory Diseases Market by Type
  1. 4.1 Global AI in Respiratory Diseases Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AI in Respiratory Diseases Market Size by Type (2021-2032)
  3. 4.3 Global AI in Respiratory Diseases Market Size Share by Type (2021-2032)
5 AI in Respiratory Diseases Market by Application
  1. 5.1 Global AI in Respiratory Diseases Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AI in Respiratory Diseases Market Size by Application (2021-2032)
  3. 5.3 Global AI in Respiratory Diseases Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 ArtiQ
  2. 6.1.1 ArtiQ Company Information
  3. 6.1.2 ArtiQ Business Overview
  4. 6.1.3 ArtiQ AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 ArtiQ AI in Respiratory Diseases Product Portfolio
  6. 6.1.5 ArtiQ Recent Developments
  7. 6.2 Philips Healthcare
  8. 6.2.1 Philips Healthcare Company Information
  9. 6.2.2 Philips Healthcare Business Overview
  10. 6.2.3 Philips Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Philips Healthcare AI in Respiratory Diseases Product Portfolio
  12. 6.2.5 Philips Healthcare Recent Developments
  13. 6.3 GE Healthcare
  14. 6.3.1 GE Healthcare Company Information
  15. 6.3.2 GE Healthcare Business Overview
  16. 6.3.3 GE Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GE Healthcare AI in Respiratory Diseases Product Portfolio
  18. 6.3.5 GE Healthcare Recent Developments
  19. 6.4 Siemens Healthineers
  20. 6.4.1 Siemens Healthineers Company Information
  21. 6.4.2 Siemens Healthineers Business Overview
  22. 6.4.3 Siemens Healthineers AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Siemens Healthineers AI in Respiratory Diseases Product Portfolio
  24. 6.4.5 Siemens Healthineers Recent Developments
  25. 6.5 Swaasa AI
  26. 6.5.1 Swaasa AI Company Information
  27. 6.5.2 Swaasa AI Business Overview
  28. 6.5.3 Swaasa AI AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Swaasa AI AI in Respiratory Diseases Product Portfolio
  30. 6.5.5 Swaasa AI Recent Developments
  31. 6.6 THIRONA
  32. 6.6.1 THIRONA Company Information
  33. 6.6.2 THIRONA Business Overview
  34. 6.6.3 THIRONA AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 THIRONA AI in Respiratory Diseases Product Portfolio
  36. 6.6.5 THIRONA Recent Developments
  37. 6.7 DeepMind Health
  38. 6.7.1 DeepMind Health Company Information
  39. 6.7.2 DeepMind Health Business Overview
  40. 6.7.3 DeepMind Health AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 DeepMind Health AI in Respiratory Diseases Product Portfolio
  42. 6.7.5 DeepMind Health Recent Developments
  43. 6.8 Verily
  44. 6.8.1 Verily Company Information
  45. 6.8.2 Verily Business Overview
  46. 6.8.3 Verily AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Verily AI in Respiratory Diseases Product Portfolio
  48. 6.8.5 Verily Recent Developments
  49. 6.9 VIDA Diagnostics Inc
  50. 6.9.1 VIDA Diagnostics Inc Company Information
  51. 6.9.2 VIDA Diagnostics Inc Business Overview
  52. 6.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 VIDA Diagnostics Inc AI in Respiratory Diseases Product Portfolio
  54. 6.9.5 VIDA Diagnostics Inc Recent Developments
  55. 6.10 Icometrix
  56. 6.10.1 Icometrix Company Information
  57. 6.10.2 Icometrix Business Overview
  58. 6.10.3 Icometrix AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Icometrix AI in Respiratory Diseases Product Portfolio
  60. 6.10.5 Icometrix Recent Developments
  61. 6.11 Infervision
  62. 6.11.1 Infervision Company Information
  63. 6.11.2 Infervision Business Overview
  64. 6.11.3 Infervision AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Infervision AI in Respiratory Diseases Product Portfolio
  66. 6.11.5 Infervision Recent Developments
  67. 6.12 PneumoWave
  68. 6.12.1 PneumoWave Company Information
  69. 6.12.2 PneumoWave Business Overview
  70. 6.12.3 PneumoWave AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 PneumoWave AI in Respiratory Diseases Product Portfolio
  72. 6.12.5 PneumoWave Recent Developments
  73. 6.13 Respiray
  74. 6.13.1 Respiray Company Information
  75. 6.13.2 Respiray Business Overview
  76. 6.13.3 Respiray AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Respiray AI in Respiratory Diseases Product Portfolio
  78. 6.13.5 Respiray Recent Developments
  79. 6.14 Dectrocel Healthcare
  80. 6.14.1 Dectrocel Healthcare Company Information
  81. 6.14.2 Dectrocel Healthcare Business Overview
  82. 6.14.3 Dectrocel Healthcare AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Dectrocel Healthcare AI in Respiratory Diseases Product Portfolio
  84. 6.14.5 Dectrocel Healthcare Recent Developments
  85. 6.15 Zynnon
  86. 6.15.1 Zynnon Company Information
  87. 6.15.2 Zynnon Business Overview
  88. 6.15.3 Zynnon AI in Respiratory Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Zynnon AI in Respiratory Diseases Product Portfolio
  90. 6.15.5 Zynnon Recent Developments
7 North America
  1. 7.1 North America AI in Respiratory Diseases Market Size (2021-2032)
  2. 7.2 North America AI in Respiratory Diseases Market Size by Type
  3. 7.2.1 North America AI in Respiratory Diseases Market Size by Type (2021-2026)
  4. 7.2.2 North America AI in Respiratory Diseases Market Size by Type (2027-2032)
  5. 7.2.3 North America AI in Respiratory Diseases Market Share by Type (2021-2032)
  6. 7.3 North America AI in Respiratory Diseases Market Size by Application
  7. 7.3.1 North America AI in Respiratory Diseases Market Size by Application (2021-2026)
  8. 7.3.2 North America AI in Respiratory Diseases Market Size by Application (2027-2032)
  9. 7.3.3 North America AI in Respiratory Diseases Market Share by Application (2021-2032)
  10. 7.4 North America AI in Respiratory Diseases Market Size by Country
  11. 7.4.1 North America AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AI in Respiratory Diseases Market Size by Country (2021-2026)
  13. 7.4.3 North America AI in Respiratory Diseases Market Size by Country (2027-2032)
  14. 7.4.4 North America AI in Respiratory Diseases Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AI in Respiratory Diseases Market Size (2021-2032)
  2. 8.2 Europe AI in Respiratory Diseases Market Size by Type
  3. 8.2.1 Europe AI in Respiratory Diseases Market Size by Type (2021-2026)
  4. 8.2.2 Europe AI in Respiratory Diseases Market Size by Type (2027-2032)
  5. 8.2.3 Europe AI in Respiratory Diseases Market Share by Type (2021-2032)
  6. 8.3 Europe AI in Respiratory Diseases Market Size by Application
  7. 8.3.1 Europe AI in Respiratory Diseases Market Size by Application (2021-2026)
  8. 8.3.2 Europe AI in Respiratory Diseases Market Size by Application (2027-2032)
  9. 8.3.3 Europe AI in Respiratory Diseases Market Share by Application (2021-2032)
  10. 8.4 Europe AI in Respiratory Diseases Market Size by Country
  11. 8.4.1 Europe AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AI in Respiratory Diseases Market Size by Country (2021-2026)
  13. 8.4.3 Europe AI in Respiratory Diseases Market Size by Country (2027-2032)
  14. 8.4.4 Europe AI in Respiratory Diseases Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AI in Respiratory Diseases Market Size (2021-2032)
  2. 9.2 China AI in Respiratory Diseases Market Size by Type
  3. 9.2.1 China AI in Respiratory Diseases Market Size by Type (2021-2026)
  4. 9.2.2 China AI in Respiratory Diseases Market Size by Type (2027-2032)
  5. 9.2.3 China AI in Respiratory Diseases Market Share by Type (2021-2032)
  6. 9.3 China AI in Respiratory Diseases Market Size by Application
  7. 9.3.1 China AI in Respiratory Diseases Market Size by Application (2021-2026)
  8. 9.3.2 China AI in Respiratory Diseases Market Size by Application (2027-2032)
  9. 9.3.3 China AI in Respiratory Diseases Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AI in Respiratory Diseases Market Size (2021-2032)
  2. 10.2 Asia AI in Respiratory Diseases Market Size by Type
  3. 10.2.1 Asia AI in Respiratory Diseases Market Size by Type (2021-2026)
  4. 10.2.2 Asia AI in Respiratory Diseases Market Size by Type (2027-2032)
  5. 10.2.3 Asia AI in Respiratory Diseases Market Share by Type (2021-2032)
  6. 10.3 Asia AI in Respiratory Diseases Market Size by Application
  7. 10.3.1 Asia AI in Respiratory Diseases Market Size by Application (2021-2026)
  8. 10.3.2 Asia AI in Respiratory Diseases Market Size by Application (2027-2032)
  9. 10.3.3 Asia AI in Respiratory Diseases Market Share by Application (2021-2032)
  10. 10.4 Asia AI in Respiratory Diseases Market Size by Country
  11. 10.4.1 Asia AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AI in Respiratory Diseases Market Size by Country (2021-2026)
  13. 10.4.3 Asia AI in Respiratory Diseases Market Size by Country (2027-2032)
  14. 10.4.4 Asia AI in Respiratory Diseases Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AI in Respiratory Diseases Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AI in Respiratory Diseases Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AI in Respiratory Diseases Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AI in Respiratory Diseases Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AI in Respiratory Diseases Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst